Stock listing
Shanghai:600998 Jointown Pharmaceutical Group Co., Ltd. (九州通) 股价
Follow Jointown Pharmaceutical Group Co., Ltd. into a list and get an email when it puts out news.
Share price · SSE:600998
¥5.17 CNY -0.15 (-2.8%)
Close on Nov 20, 2026
- Day range
- ¥5.11 – ¥5.21 CNYNov 20, 2026
- Volume
- 34.79M sharesNov 20, 2026
- Market cap
- ¥26.07B CNYAt the close on Nov 20, 2026 · price × 5.04B shares outstanding
- 52-week range
- ¥4.48 – ¥5.84 CNYLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ¥191.5M CNYMedian day 35.34M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SSE:600998 · CNY, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ¥5.17 | -0.15 | -2.8% | ¥5.19 | ¥5.21 | ¥5.11 | 34,788,657 | |
| ¥5.32 | +0.05 | +0.9% | ¥5.24 | ¥5.32 | ¥5.23 | 32,672,422 | |
| ¥5.27 | +0.02 | +0.4% | ¥5.22 | ¥5.29 | ¥5.20 | 35,196,319 | |
| ¥5.25 | +0.16 | +3.1% | ¥5.10 | ¥5.26 | ¥5.09 | 46,507,249 | |
| ¥5.09 | -0.05 | -1.0% | ¥5.12 | ¥5.14 | ¥5.06 | 31,955,128 | |
| ¥5.14 | -0.01 | -0.2% | ¥5.15 | ¥5.16 | ¥5.05 | 36,613,967 | |
| ¥5.15 | -0.03 | -0.6% | ¥5.16 | ¥5.22 | ¥5.12 | 27,299,151 | |
| ¥5.18 | -0.01 | -0.2% | ¥5.20 | ¥5.21 | ¥5.15 | 24,223,658 | |
| ¥5.19 | -0.05 | -1.0% | ¥5.25 | ¥5.28 | ¥5.19 | 25,409,657 | |
| ¥5.24 | -0.01 | -0.2% | ¥5.19 | ¥5.28 | ¥5.15 | 36,074,228 | |
| ¥5.25 | -0.09 | -1.7% | ¥5.34 | ¥5.36 | ¥5.21 | 61,890,882 | |
| ¥5.34 | +0.06 | +1.1% | ¥5.29 | ¥5.41 | ¥5.28 | 66,071,607 | |
| ¥5.28 | -0.04 | -0.8% | ¥5.33 | ¥5.34 | ¥5.22 | 44,511,822 | |
| ¥5.32 | +0.10 | +1.9% | ¥5.23 | ¥5.33 | ¥5.22 | 69,762,527 | |
| ¥5.22 | +0.07 | +1.4% | ¥5.15 | ¥5.27 | ¥5.10 | 57,544,066 | |
| ¥5.15 | -0.02 | -0.4% | ¥5.17 | ¥5.19 | ¥5.09 | 36,562,560 | |
| ¥5.17 | +0.07 | +1.4% | ¥5.11 | ¥5.18 | ¥5.06 | 41,033,319 | |
| ¥5.10 | -0.03 | -0.6% | ¥5.13 | ¥5.23 | ¥5.10 | 49,150,258 | |
| ¥5.13 | +0.24 | +4.9% | ¥4.91 | ¥5.20 | ¥4.87 | 81,975,394 | |
| ¥4.89 | -0.03 | -0.6% | ¥4.93 | ¥4.94 | ¥4.80 | 37,285,726 | |
| ¥4.92 | -0.07 | -1.4% | ¥4.98 | ¥4.99 | ¥4.88 | 25,501,759 | |
| ¥4.99 | +0.02 | +0.4% | ¥5.00 | ¥5.02 | ¥4.94 | 22,833,108 | |
| ¥4.97 | -0.04 | -0.8% | ¥5.01 | ¥5.05 | ¥4.93 | 24,889,466 | |
| ¥5.01 | +0.08 | +1.6% | ¥4.90 | ¥5.06 | ¥4.89 | 36,882,469 | |
| ¥4.93 | -0.09 | -1.8% | ¥5.02 | ¥5.08 | ¥4.88 | 44,936,774 | |
| ¥5.02 | -0.08 | -1.6% | ¥5.09 | ¥5.11 | ¥4.98 | 35,404,954 | |
| ¥5.10 | +0.07 | +1.4% | ¥5.05 | ¥5.12 | ¥5.02 | 41,999,668 | |
| ¥5.03 | -0.09 | -1.8% | ¥5.11 | ¥5.15 | ¥5.03 | 38,516,307 | |
| ¥5.12 | +0.04 | +0.8% | ¥5.09 | ¥5.15 | ¥5.07 | 45,501,391 | |
| ¥5.08 | +0.02 | +0.4% | ¥5.08 | ¥5.13 | ¥5.05 | 42,219,388 | |
| ¥5.06 | +0.01 | +0.2% | ¥5.08 | ¥5.19 | ¥5.04 | 68,437,749 | |
| ¥5.05 | +0.09 | +1.8% | ¥4.98 | ¥5.06 | ¥4.95 | 44,766,141 | |
| ¥4.96 | +0.03 | +0.6% | ¥4.89 | ¥4.98 | ¥4.88 | 26,791,678 | |
| ¥4.93 | +0.09 | +1.9% | ¥4.84 | ¥4.93 | ¥4.84 | 30,999,984 | |
| ¥4.84 | -0.05 | -1.0% | ¥4.87 | ¥4.91 | ¥4.83 | 20,864,300 | |
| ¥4.89 | +0.02 | +0.4% | ¥4.87 | ¥4.92 | ¥4.78 | 37,628,798 | |
| ¥4.87 | -0.14 | -2.8% | ¥5.00 | ¥5.01 | ¥4.86 | 54,571,897 | |
| ¥5.01 | +0.01 | +0.2% | ¥5.00 | ¥5.05 | ¥4.92 | 38,281,648 | |
| ¥5.00 | -0.04 | -0.8% | ¥5.02 | ¥5.07 | ¥4.98 | 34,355,062 | |
| ¥5.04 | +0.03 | +0.6% | ¥4.98 | ¥5.09 | ¥4.98 | 31,874,532 | |
| ¥5.01 | -0.01 | -0.2% | ¥5.00 | ¥5.04 | ¥4.91 | 32,888,179 | |
| ¥5.02 | -0.06 | -1.2% | ¥5.08 | ¥5.11 | ¥5.00 | 27,181,250 | |
| ¥5.08 | +0.11 | +2.2% | ¥4.97 | ¥5.09 | ¥4.94 | 35,277,290 | |
| ¥4.97 | -0.07 | -1.4% | ¥5.04 | ¥5.04 | ¥4.93 | 25,244,202 | |
| ¥5.04 | -0.01 | -0.2% | ¥5.02 | ¥5.06 | ¥4.99 | 20,616,647 | |
| ¥5.05 | -0.02 | -0.4% | ¥5.07 | ¥5.08 | ¥5.01 | 17,862,472 | |
| ¥5.07 | 0.00 | 0.0% | ¥5.07 | ¥5.10 | ¥5.00 | 28,743,162 | |
| ¥5.07 | +0.02 | +0.4% | ¥5.06 | ¥5.10 | ¥5.02 | 39,124,064 | |
| ¥5.05 | +0.05 | +1.0% | ¥5.01 | ¥5.05 | ¥4.97 | 34,305,348 | |
| ¥5.00 | +0.05 | +1.0% | ¥4.92 | ¥5.03 | ¥4.92 | 33,261,628 | |
| ¥4.95 | +0.02 | +0.4% | ¥4.95 | ¥5.01 | ¥4.90 | 28,827,134 | |
| ¥4.93 | +0.09 | +1.9% | ¥4.81 | ¥4.94 | ¥4.81 | 43,562,205 | |
| ¥4.84 | -0.06 | -1.2% | ¥4.91 | ¥4.91 | ¥4.81 | 43,704,007 | |
| ¥4.90 | -0.04 | -0.8% | ¥4.91 | ¥4.92 | ¥4.87 | 21,274,645 | |
| ¥4.94 | 0.00 | 0.0% | ¥4.94 | ¥4.98 | ¥4.87 | 30,155,670 | |
| ¥4.94 | +0.02 | +0.4% | ¥4.90 | ¥4.97 | ¥4.90 | 28,483,392 | |
| ¥4.92 | 0.00 | 0.0% | ¥4.90 | ¥4.93 | ¥4.86 | 26,566,582 | |
| ¥4.92 | +0.01 | +0.2% | ¥4.87 | ¥4.93 | ¥4.83 | 31,962,407 | |
| ¥4.91 | -0.13 | -2.6% | ¥5.00 | ¥5.02 | ¥4.83 | 47,400,300 | |
| ¥5.04 | +0.09 | +1.8% | ¥4.96 | ¥5.06 | ¥4.95 | 44,635,907 |
Splits
1 split · SSE:600998 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 149-for-100 | Split |
- Ticker
- Shanghai:600998
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- Shanghai
- Currency
- CNY
What changed lately
Latest news release · Nov 20, 2026
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Release of Pledge and Pledge of Shares Held by Shareholders
Latest news
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Release of Pledge and Pledge of Shares Held by Shareholders
Nov 20, 2026
Closed ¥5.17 (-2.8%) on Nov 20, 2026
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantees for Subsidiaries
Nov 18, 2026
Closed ¥5.32 (+0.9%) on Nov 18, 2026
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026
Nov 10, 2026
Closed ¥5.18 (-0.2%) on Nov 10, 2026
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 1st Meeting of the 7th Board of Directors
Nov 10, 2026
Closed ¥5.18 (-0.2%) on Nov 10, 2026
(600998)"Jointown Pharmaceutical Group Co., Ltd."Indicative Announcement on the 4th Extraordinary General Meeting in 2026
Nov 3, 2026
Closed ¥5.28 (-0.8%) on Nov 3, 2026
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Provision of Online Voting Reminder Service for General Meeting
Nov 3, 2026
Closed ¥5.28 (-0.8%) on Nov 3, 2026
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Outline of Q3 2026 Performance Briefing
Nov 3, 2026
Closed ¥5.28 (-0.8%) on Nov 3, 2026
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Election of Employee Representative Director for the 7th Board of Directors
Nov 3, 2026
Closed ¥5.28 (-0.8%) on Nov 3, 2026
Jointown Pharmaceutical Group Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 78 in the last 12 months · 95 in all · newest Nov 20, 2026 · oldest 2025
Valuation
P/E 13.3× against a median of 46.0×: the lowest of 8 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- ¥5.04B CNY
- P/E
- 13.3×
- EV/sales
- 0.0×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 0.9×
- Gross margin
- 8.0%
- Operating margin
- 2.5%
- Net margin
- 1.1%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Jointown Pharmaceutical Group Co., Ltd. Class A · SSE:600998 | US$3.91B | US$755.9M | 13.3× | 0.0× | n/a | 0.9× | 1.1% | 0.1× | n/a |
| Option Care Health, Inc. · NASDAQ:OPCH | US$4.73B | US$5.59B | 22.0× | 1.0× | 13.7× | 3.6× | 3.7% | 0.9× | 0.03 |
| Global Health Limited · NSE:MEDANTA | US$4.29B | US$4.28B | 64.3× | 7.9× | 35.5× | 9.2× | 12.2% | 0.3× | n/a |
| Narayana Hrudayalaya Ltd. · NSE:NH | US$4.26B | US$4.59B | 46.0× | 4.1× | 22.4× | 7.9× | 8.4% | 1.2× | n/a |
| Bumrungrad Hospital Public Co., Ltd. · SET:BH | US$4.17B | US$3.96B | 18.6× | 5.3× | 13.5× | 5.2× | 29.8% | 0.0× | n/a |
| Doximity, Inc. · NYSE:DOCS | US$3.66B | US$2.95B | 26.2× | 4.5× | 15.3× | 3.9× | 21.1% | 0.0× | 0.74 |
| Dr. Lal PathLabs Limited · NSE:LALPATHLAB | US$3.62B | US$3.47B | 57.5× | 10.6× | 36.0× | 12.2× | 19.2% | 0.1× | n/a |
| Krishna Institute of Medical Sciences Limited · NSE:KIMS | US$3.61B | US$3.93B | 157× | 7.9× | 41.0× | 8.5× | 4.6% | 0.9× | n/a |
| Surgery Partners, Inc. · NASDAQ:SGRY | US$3.50B | US$6.21B | n/a | 1.9× | 11.5× | 2.1× | −2.6% | 1.8× | 0.94 |
| Hims & Hers Health, Inc. · NYSE:HIMS | US$3.30B | US$4.15B | n/a | 1.4× | n/a | 9.3× | −6.7% | 4.4× | 2.64 |
| Acadia Healthcare Company, Inc. · NASDAQ:ACHC | US$3.22B | US$5.41B | n/a | 1.6× | 10.1× | 1.6× | −33.1% | 1.2× | 0.82 |
| Median of the others | US$3.64B | US$4.22B | 46.0× | 4.3× | 15.3× | 6.6× | 6.5% | 0.9× | 0.82 |
Forecasts
Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.
- Price target
- 5.76 CNY · Analysts' mean
- EPS, year to Dec 2026
- 0.39 · 1 analyst
- Revenue, year to Dec 2026
- 172.7B · 2 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Liu Yichang | Vice Chairman and the Business President of Jointown Pharmaceutical Group Co., Ltd |
| Gong Yihua | Vice Chairman and the General Manager of Jointown Pharmaceutical Group Co., Ltd |
| Li Zhongchao | Director of Jointown Pharmaceutical Group Co., Ltd |
| Liu Baolin | Founder and Honorary Chairman of Jointown Pharmaceutical Group Co., Ltd |
| Liu Shulin | Founder and Honorary Vice Chairman of Jointown Pharmaceutical Group Co., Ltd |
| Liu Zhaonian | Founder and Vice Chairman of Jointown Pharmaceutical Group Co., Ltd |
| Wang Qi | Director of Jointown Pharmaceutical Group Co., Ltd |
Board
| Director | Role |
|---|---|
| Liu Baolin | Founder and Honorary Chairman of Jointown Pharmaceutical Group Co., Ltd |
| Liu Changyun | Chairman of Jointown Pharmaceutical Group Co., Ltd |
| Ai Hua | Independent Director of Jointown Pharmaceutical Group Co., Ltd |
| Gong Yihua | Vice Chairman and the General Manager of Jointown Pharmaceutical Group Co., Ltd |
| Liu Dengpan | Vice Chairman of Jointown Pharmaceutical Group Co., Ltd |
| Liu Shulin | Founder and Honorary Vice Chairman of Jointown Pharmaceutical Group Co., Ltd |
| Liu Yichang | Vice Chairman and the Business President of Jointown Pharmaceutical Group Co., Ltd |
| Liu Zhaonian | Founder and Vice Chairman of Jointown Pharmaceutical Group Co., Ltd |
| Lu Yindi | Independent Director of Jointown Pharmaceutical Group Co., Ltd |
| Tang Guliang | Independent Director of Jointown Pharmaceutical Group Co., Ltd |
| Wang Ying | Independent Director of Jointown Pharmaceutical Group Co., Ltd |
| Wu Zhilong | Employee Representative Director of Jointown Pharmaceutical Group Co., Ltd |
| Zeng Xiangquan | Independent Director of Jointown Pharmaceutical Group Co., Ltd |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Aug 24, 2026 · After close | 0.0% |
| Q1 2026 | Apr 27, 2026 · After close | −1.3% |
| Q2 2025 | Aug 26, 2025 · After close | −3.1% |
| Q1 2025 | Apr 28, 2025 · After close | +5.0% |
| Q3 2024 | Oct 28, 2024 · After close | −2.3% |
| Q1 2024 | Apr 27, 2024 · Before open | −1.6% |
| Q4 2023 | Jan 5, 2024 · After close | −2.2% |
| Q3 2023 | Oct 26, 2023 · After close | −0.1% |
| Q2 2023 | Aug 28, 2023 · Before open | +2.3% |
| Q1 2023 | Apr 24, 2023 · After close | +5.0% |
All 16 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2022 | Oct 24, 2022 · After close | +0.2% |
| Q2 2022 | Aug 22, 2022 · After close | +4.9% |
| Q1 2022 | Apr 25, 2022 · After close | −10.0% |
| Quarter to Sep 30, 2021 | Oct 25, 2021 · After close | −8.4% |
| Quarter to Jun 30, 2021 | Aug 24, 2021 · After close | +3.4% |
| Quarter to Mar 31, 2021 | Apr 26, 2021 · After close | −3.9% |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Medium-term notes (3rd tranche for 2026, supporting the elderly care industry) Closed: CNY 500M raised · 招商银行股份有限公司 Dealers: 招商银行股份有限公司 (lead) | Oct 31, 2026 | US$75.14M |
| Asset-backed commercial paper (second tranche for 2026) Announced: debt | Aug 28, 2026 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in CNY
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 161.4B | 151.8B | 150.1B | 140.4B | 122.4B | 110.9B | 99.5B | 87.1B | 73.9B | 61.6B |
| Cost of revenue | 148.8B | 140.1B | 138.1B | 129.6B | 112.6B | 101.0B | 90.8B | 79.6B | 67.7B | 56.8B |
| Gross profit | 12.5B | 11.7B | 12.0B | 10.9B | 9.77B | 9.88B | 8.67B | 7.49B | 6.21B | 4.80B |
| Research and development | 128.8M | 146.7M | 196.6M | 178.4M | 194.9M | 126.6M | 74.1M | 76.2M | 73.1M | 56.4M |
| Selling, general and administrative | 3.14B | 2.78B | 2.73B | 2.47B | 2.38B | 2.04B | 1.86B | 1.74B | 1.49B | 1.18B |
| Operating income | 4.04B | 3.64B | 3.02B | 2.85B | 3.59B | 4.35B | 2.30B | 1.83B | 1.94B | 1.05B |
| Depreciation and amortization | 836.4M | 857.2M | 774.9M | 736.3M | 656.8M | 514.3M | 497.1M | 403.1M | 351.5M | 277.4M |
| EBITDA | 4.88B | 4.49B | 3.80B | 3.59B | 4.25B | 4.87B | 2.80B | 2.23B | 2.29B | 1.32B |
| Interest expense | 1.01B | 1.33B | 1.32B | 1.31B | 1.23B | 1.13B | 1.34B | 966.0M | 756.7M | 701.0M |
| Income before tax | 3.29B | 3.64B | 2.99B | 2.84B | 3.36B | 4.33B | 2.32B | 1.83B | 1.92B | 1.11B |
| Income tax | 851.0M | 701.2M | 552.6M | 754.9M | 948.9M | 536.0M | 449.3M | 451.8M | 201.3M | |
| Net income | 2.25B | 2.51B | 2.17B | 2.08B | 2.45B | 3.08B | 1.73B | 1.34B | 1.45B | 876.7M |
| Earnings per share, basic | 0.45 | 0.50 | 0.43 | 0.40 | 0.47 | 0.58 | 0.31 | 0.27 | 0.32 | 0.20 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 18.8B | 17.4B | 16.9B | 17.2B | 14.7B | 14.8B | 12.2B | 12.7B | 8.54B | 5.24B |
| Short-term investments | 105.8M | 972.3M | 90.0M | 319.7M | 3.60B | 15.3M | 967.4K | 7.03M | ||
| Receivables | 28.9B | 37.4B | 34.1B | 30.5B | 32.7B | 32.5B | 29.1B | 26.0B | 20.0B | 14.5B |
| Inventory | 30.3B | 22.9B | 20.1B | 17.2B | 15.5B | 14.8B | 14.1B | 13.9B | 12.2B | 10.2B |
| Current assets | 95.3B | 84.2B | 75.6B | 75.7B | 71.2B | 66.2B | 58.9B | 57.1B | 43.5B | 32.2B |
| Property, plant and equipment | 8.65B | 8.52B | 7.41B | 6.51B | 6.03B | 5.29B | 4.40B | |||
| Goodwill | 1.35B | 799.4M | 759.7M | 813.4M | 581.4M | 554.3M | 342.5M | 126.2M | 145.2M | 87.4M |
| Total assets | 116.4B | 102.4B | 92.8B | 92.3B | 85.9B | 80.8B | 71.1B | 66.7B | 52.0B | 38.7B |
| Accounts payable | 54.1B | 46.5B | 40.1B | 33.8B | 34.2B | 26.7B | 28.0B | 25.4B | 19.2B | 16.2B |
| Current liabilities | 76.4B | 66.4B | 60.1B | 59.7B | 55.4B | 51.3B | 45.9B | 44.3B | 30.7B | 25.3B |
| Long-term debt | 1.64B | 1.02B | 2.34B | 2.98B | 2.38B | 3.20B | 2.72B | 1.63B | 1.46B | 1.29B |
| Total debt | 11.7B | 12.6B | 15.2B | 17.0B | 17.7B | 14.6B | 11.9B | 8.50B | 6.82B | |
| Total liabilities | 79.5B | 68.8B | 63.3B | 63.6B | 58.9B | 55.2B | 49.2B | 46.3B | 32.5B | 26.7B |
| Shareholders' equity | 28.6B | 27.2B | 24.0B | 24.6B | 23.4B | 21.8B | 18.8B | 18.5B | 18.3B | 11.3B |
| Shares outstanding | 5.04B | 5.01B | 5.06B | 5.27B | 5.19B | 5.34B | 5.53B | 5.01B | 4.58B | 4.37B |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 3.44B | 3.08B | 4.78B | 3.99B | 3.46B | 3.44B | 2.77B | 1.22B | -1.01B | 431.3M |
| Capital spending | -1.40B | -975.4M | -1.05B | -1.24B | -1.39B | -1.46B | -1.19B | -1.81B | -1.09B | -1.15B |
| Free cash flow | 2.04B | 2.11B | 3.70B | 2.74B | 2.07B | 1.99B | 1.58B | -592.8M | -2.10B | -719.2M |
| Cash from investing | -1.59B | -1.36B | 1.49B | -2.54B | -1.27B | -1.24B | -1.52B | -2.00B | -1.50B | |
| Cash from financing | -2.50B | -2.24B | -4.90B | -2.02B | -183.5M | -2.84B | 2.25B | 6.08B | -415.7M | |
| Dividends paid | -1.48B | -1.55B | -936.9M | -548.6M | -914.4M | -737.7M | -187.4M | -967.1M | -709.5M | -723.0M |
| Share buybacks | -268.2M | -2.00B | -425.8M | -113.8K | -300.0M | -600.0M | ||||
| Change in cash | 783.8M | -1.01B | 1.15B | 583.0M | -1.10B | 1.98B | -1.31B | 1.95B | 3.07B | -1.48B |
Filings
All 95 filings
Cap table
Built by 6ix from Jointown Pharmaceutical Group Co., Ltd. Class A’s releases · as of Oct 31, 2026
- Common shares
- 5,042,470,234
- Fully diluted
- 5,042,470,234
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 5,042,470,234 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 5,042,470,234 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ai Hua | Independent Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Gong Yihua | Vice Chairman and the General Manager of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Liu Baolin | Founder and Honorary Chairman of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Liu Changyun | Chairman of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Liu Dengpan | Vice Chairman of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Liu Shulin | Founder and Honorary Vice Chairman of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Liu Yichang | Vice Chairman and the Business President of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Liu Zhaonian | Founder and Vice Chairman of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Li Zhongchao | Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Lu Yindi | Independent Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
All 15 people
| Person | Seat |
|---|---|
| Tang Guliang | Independent Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Wang Qi | Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Wang Ying | Independent Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Wu Zhilong | Employee Representative Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
| Zeng Xiangquan | Independent Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026 |
Log in to ask 6ix AI your own questions about Jointown Pharmaceutical Group Co., Ltd.